North America Sterile Compounding Pharmacies Market Size, Share, Comprehensive Analysis, Opportunity Assessment by 2028


The North America Sterile Compounding Pharmacies Market is expected to grow from US$ 1,997.45 million in 2021 to US$ 3,218.93 million by 2028; it is estimated to grow at a CAGR of 7.1% from 2021 to 2028.

Personalized Medicine and the Growth of North America Sterile Compounding Pharmacies Market

Personalized medicine continues to gain momentum due to its targeted drug delivery and dosing capabilities tailored to individual patient needs. According to the Personalized Medicine Coalition, personalized therapies have made up over a quarter of all new drug approvals since 2015. Notably, the FDA’s Center for Drug Evaluation and Research (CDER) approved 53 new molecular entities (NMEs) in 2020, with 19 of the 49 therapeutic NMEs—approximately 39%—classified as personalized medicines. This marks the highest percentage since 2018, when personalized medicines comprised 42% of NMEs.

North America Sterile Compounding Pharmacies Market medications serve as an advanced alternative to traditional pharmacy compounding, particularly for patients whose medical needs aren't met by standard FDA-approved drugs. Sterile compounding pharmacies can produce personalized formulations—such as injectables or other dosage forms—tailored to specific strengths or to eliminate allergens found in commercial medications. These customized solutions are especially critical for patients who do not respond to conventional treatments or require different administration routes.

With personalized medicine on the rise, the growing demand for precision therapies has created new revenue opportunities for sterile compounding pharmacies. As a result, many leading players in the market are pursuing inorganic growth strategies, focusing on innovation and the development of advanced products, especially within North America.

During the COVID-19 pandemic, both hospital and community compounding facilities played vital roles in supporting healthcare needs. The surge in demand for personal protective equipment (PPE) and other critical supplies challenged hospitals to maintain safe and compliant sterile compounding operations. In response, the United States Pharmacopeia (USP) issued new guidance to address these operational concerns. Hospitals have had to continuously adapt their sterile compounding practices based on fluctuating equipment availability and institutional demands. Additionally, the Government of Canada reported several pandemic-related disruptions—including supply chain issues and limited access to contract service providers—which further affected equipment maintenance and external calibration tasks. These challenges significantly impacted the North America Sterile Compounding Pharmacies Market.

Strategic Insights for the North America Sterile Compounding Pharmacies Market

Strategic insights into the North America Sterile Compounding Pharmacies Market landscape offer valuable, data-driven perspectives on industry trends, key players, and regional dynamics. These insights equip stakeholders with actionable recommendations to help identify underserved market segments and craft unique value propositions. By leveraging analytics, industry players—whether investors, manufacturers, or healthcare providers—can better anticipate market shifts and stay ahead of evolving demands. A forward-looking approach is essential for long-term success in this dynamic space. Ultimately, well-informed strategic insights empower stakeholders to make decisions that drive growth, enhance competitiveness, and achieve sustainable business outcomes in the North America Sterile Compounding Pharmacies Market.

North America Sterile Compounding Pharmacies Market Segmentation        

North America Sterile Compounding Pharmacies Market – By Product

  • Injectable Drugs
  • Infusions

North America Sterile Compounding Pharmacies Market – By Route of Administration

  • Intravenous
  • Intramuscular
  • Subcutaneous

North America Sterile Compounding Pharmacies Market– By Country

  • US
  • Canada
  • Mexico

North America Sterile Compounding Pharmacies Market-Companies Mentioned

  • Avella Specialty Pharmacy
  • B. Braun Melsungen AG
  • Fagron, Inc.
  • Fresenius Kabi AG
  • Pace Pharmacy
  • Pavilion Compounding Pharmacy, LLC.
  • Pencol Compounding Pharmacy
  • PharMEDium Healthcare Holdings, Inc.
  • SandsRx
  • Triangle Compounding Pharmacy

Other Reports: 

North America Corrugated Boards Market: https://business-news-insights.blogspot.com/2025/04/north-america-corrugated-boards-market.html 

North America Molecular Diagnostics Market: https://sites.google.com/view/molecular-diagnostics-n/home 

North America Urinalysis Market: https://penzu.com/p/8a90a8233279b794 

North America Aramid Fiber Market: https://postyourarticle.com/north-america-aramid-fiber-market-technological-advancement-and-opportunities-to-2028/ 

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

Author’s Bio:

Suryakant Gadekar

Senior Market Research Expert at Business Market Insights 

Comments

Popular posts from this blog

North America Small Satellite Market Current Status by 2028 Top Players

North America Small Satellite Market Trends, Opportunity and Forecast 2022 to 2028

North America Small Satellite Market Latest Innovations, Top Players Forecast 2028